T-cell therapy, originally developed for haematological malignancies, has recently emerged as a promising therapy for ...

CAR T-cell therapy is an advanced immunotherapy that harnesses the power of a patient’s own immune cells, specifically ...

Researchers at the University of Pennsylvania have unveiled an innovative approach to cancer treatment that leverages tiny ...

Clinicians may one day be able to treat immune checkpoint inhibitor-related myocarditis without disrupting cancer therapy, findings from a cellular investigation showed.Individuals who die of immune ...

Chimeric antigen receptor-T (CAR-T) cell therapy, initially successful in hematologic malignancies, presents a promising avenue for treating solid tumors, including CRC. This review explores the ...

VMMC and Safdarjung Hospital successfully performed their inaugural CAR-T cell therapy for cancer treatment, marking a ...

A new research paper was published in Oncotarget's Volume 16 on January 20, 2025, titled "Anti-correlation of KLRG1 and PD-1 expression in human tumor CD8 T cells." ...

Caregiving can take many forms, often requiring a profound shift in daily life. While navigating a disease is an immense ...

A study shares new insights into how two of the most common types of chimeric antigen receptor (CAR) T cells kill cancer. Investigators examined how molecular dynamics at the immune synapse -- where ...

Cases of secondary tumors have been reported as a possible adverse reaction to the treatment of certain blood cancers with CAR T-cells. A recent analysis of the cases reported to the ...

"The first CAR-T therapy at Safdarjung Hospital was administered to a patient diagnosed with refractory Non-Hodgkin lymphoma, a type of blood cancer that resists conventional treatments," the ...